ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,469.17
      0.95%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Invitae Corporation (NVTA)

      7. Invitae Corporation (NVTA) News

      NVTA

      Invitae (NVTA)

      Invitae Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:NVTA
      DateTimeSourceHeadlineSymbolCompany
      04/19/202110:00AMPR Newswire (US)AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation Join the Access to Comprehensive Genomic Profiling CoalitionNYSE:NVTAInvitae Corporation
      04/15/20217:30AMPR Newswire (US)Study finds risk-causing genetic changes in nearly 1 in 6 patients with colorectal cancerNYSE:NVTAInvitae Corporation
      04/08/20214:29PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
      04/08/20217:30AMPR Newswire (US)Invitae joins NIH-sponsored study aimed at improving understanding of the links between genes and cancer, heart disease and o...NYSE:NVTAInvitae Corporation
      04/05/20214:13PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
      04/05/20214:11PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NYSE:NVTAInvitae Corporation
      04/05/20217:30AMPR Newswire (US)Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth InitiativesNYSE:NVTAInvitae Corporation
      04/05/20217:30AMPR Newswire (US)Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwideNYSE:NVTAInvitae Corporation
      04/01/20217:30AMPR Newswire (US)Invitae introduces new program to increase access to genetic testing for adult neurodegenerative conditionsNYSE:NVTAInvitae Corporation
      03/23/20214:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
      03/23/20214:27PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
      03/19/20215:06PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NYSE:NVTAInvitae Corporation
      03/19/20215:05PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NYSE:NVTAInvitae Corporation
      03/11/20217:30AMPR Newswire (US)Invitae Releases Inaugural Environmental, Social and Governance (ESG) ReportNYSE:NVTAInvitae Corporation
      03/04/20217:30AMPR Newswire (US)Invitae to Present at the Oppenheimer 31st Annual Healthcare ConferenceNYSE:NVTAInvitae Corporation
      03/02/20211:00AMPR Newswire (US)Pharming Group, in collaboration with Invitae Corporation, launches genetic testing program 'navigateAPDS' in US and CanadaNYSE:NVTAInvitae Corporation
      02/26/20215:38PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NYSE:NVTAInvitae Corporation
      02/26/20215:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
      02/26/20214:36PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:NVTAInvitae Corporation
      02/26/20214:10PMEdgar (US Regulatory)Annual Report (10-k)NYSE:NVTAInvitae Corporation
      02/24/20217:30AMPR Newswire (US)Invitae adds Medneon's risk assessment tools to its education and clinical support offeringsNYSE:NVTAInvitae Corporation
      02/23/20215:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
      02/23/20217:30AMPR Newswire (US)Invitae expands capabilities of its advanced clinical chatbot Gia, enhancing telemedicine support for patients and cliniciansNYSE:NVTAInvitae Corporation
      02/22/20214:05PMPR Newswire (US)Invitae to Present at The Cowen 41st Annual Healthcare ConferenceNYSE:NVTAInvitae Corporation
      02/17/20214:05PMPR Newswire (US)Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020NYSE:NVTAInvitae Corporation
      02/16/20214:41PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:NVTAInvitae Corporation
      02/16/20217:13AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:NVTAInvitae Corporation
      02/11/20215:06PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:NVTAInvitae Corporation
      02/10/20216:51PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:NVTAInvitae Corporation
      02/10/20211:44PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:NVTAInvitae Corporation
       Showing the most relevant articles for your search:NYSE:NVTA